PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)

A comprehensive search regarding programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitor monotherapy or combination therapy in neoadjuvant settings of 11 types of solid cancer was performed using the PubMed, Cochrane and Embase databases, and the abstracts of various confe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Quanying, Zhao, Shikang, Zhou, Ning, He, Jinling, Zu, Lingling, Liu, Tingwen, Song, Zuoqing, Chen, Jun, Peng, Ling, Xu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019757/
https://www.ncbi.nlm.nih.gov/pubmed/36866750
http://dx.doi.org/10.3892/ijo.2023.5497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019757/
https://www.ncbi.nlm.nih.gov/pubmed/36866750
http://dx.doi.org/10.3892/ijo.2023.5497

Ejemplares similares